• Drying Nucleic Acid LNPs: What Comparisons Show

  2026-10-13

  A source-grounded editorial assessment of drying strategies for nucleic-acid lipid nanoparticles, emphasizing what current comparisons support, where evidence is difficult to compare, and why findings from one nucleic-acid class or delivery route should not be generalized to another.

• Drying mRNA-LNPs: Evidence and Boundaries

  2026-10-12

  A 2026 review positions drying—particularly freeze-drying—as a potential strategy for improving the storage stability of mRNA and other nucleic-acid lipid nanoparticles. Its conclusions are promising but formulation- and molecule-dependent, and should not be treated as validation of any specific product, excipient, or clinical application.

• TMRE and Sodium-Driven Mitochondrial Failure

  2026-10-12

  A recent Nature Communications study links sodium overload in NECSO with impaired mitochondrial energy metabolism. TMRE can provide a readout related to mitochondrial membrane potential, but that signal is only one component of the proposed mechanism and cannot by itself establish changes in mitochondrial sodium, calcium, ATP production, or cell-death pathway identity.

• MLN4924, BipD, and the NEDD8 Evidence Gap

  2026-10-11

  The available evidence connects MLN4924’s reported upstream inhibition of NEDD8-dependent cullin activity with a published mechanism by which Burkholderia pseudomallei BipD alters host mitophagy. However, the supplied literature does not contain a direct comparison, and mechanistic overlap should not be interpreted as evidence that MLN4924 reproduces BipD biology or has anti-infective activity.

• miR-18a, ALOXE3, and Ferroptosis in Glioblastoma

  2026-10-09

  Yang et al. identify a miR-18a–ALOXE3 regulatory axis that links lipid metabolism, ferroptosis resistance, and migration in glioblastoma. The study combines human tumor observations, cellular mechanistic evidence, and orthotopic mouse modeling to support ALOXE3 as a context-dependent tumor-suppressive factor, while remaining preclinical and not yet clinically validated.

• PDHA1 Succinylation, α-KGA, and Immune Escape

  2026-10-09

  A 2025 Nature Communications study connects PDHA1 K83 succinylation with α-ketoglutarate accumulation, OXGR1–MAPK signaling, and reduced macrophage MHC-II antigen presentation in cholangiocarcinoma. The findings provide a mechanistic framework for understanding tumor–immune metabolic crosstalk and suggest that targeting succinylation may influence chemotherapy sensitivity, while remaining preclinical.

• CCK-8 in Cancer Research: Five Evidence Questions

  2026-10-08

  A source-grounded overview of what Cell Counting Kit-8 can measure, how its signal should be interpreted, and why it cannot independently establish cancer mechanisms or clinical efficacy.

• (S)-(+)-Methoprene and JH Causality

  2026-10-08

  (S)-(+)-Methoprene offers a receptor-centered lens for interpreting juvenile hormone signaling, but its meaning depends on separating downstream Met activation from upstream hormone biosynthesis. This article examines how recent miRNA–mRNA findings in locust reproduction refine the evidence framework for developmental, endocrine, and receptor biology research.

• PPM-18: From NF-κB Biology to Model Choice

  2026-10-07

  PPM-18 is an iNOS expression inhibitor that connects NF-κB signaling with nitric oxide biology. This analysis distinguishes supplier-reported anti-inflammatory findings from peer-reviewed oridonin evidence and defines where the comparison informs, but cannot replace, sepsis or bone-remodeling research.

• Cy3 RNA Labeling Kit: Mechanism and Evidence

  2026-10-07

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit is a manufacturer-described system for generating randomly Cy3-modified RNA probes through T7-mediated in vitro transcription. Its intended use in fluorescent probe applications is distinct from the peer-reviewed study of ROS-responsive lipid nanoparticles for tumor-selective mRNA delivery.

• AICAR Phosphate: AMPK Evidence Across Cell Contexts

  2026-10-06

  AICAR phosphate (Acadesine) is best interpreted through the cellular context in which AMPK is activated. This article connects B-CLL apoptosis evidence with recent findings on mitophagy and inflammation in mechanically loaded diabetic periodontal tissue, while defining the boundaries of cross-model interpretation.

• FBXO22 Degraders and 2-PCA Recruitment Ligand

  2026-10-06

  A 2025 bioRxiv preprint reports two complementary advances in targeted protein degradation: a potent, selective FBXO22 degrader and 2-pyridinecarboxaldehyde (2-PCA) as a recruitment ligand for this E3 ligase. The findings expand the chemical toolkit for studying FBXO22 and demonstrate FBXO22-dependent degradation of BRD4 and CDK12, while remaining preliminary because the study has not yet been certified by peer review.

• Sodium Stress, ΔΨm & Translational Mitochondrial Insight

  2026-10-05

  A thought-leadership analysis of how sodium-driven mitochondrial energy failure reframes ΔΨm measurement, with strategic guidance for translational researchers using TMRE as one component of a multiparametric evidence strategy.

• miRNA–mRNA Control of Juvenile Hormone Biosynthesis

  2026-10-05

  Li and colleagues identify coordinated miRNA–mRNA modules that regulate multiple juvenile hormone biosynthetic genes in the locust corpus allatum during vitellogenesis. The findings connect post-transcriptional control of hormone production with vitellogenin expression and ovarian development, while also defining limits for interpreting receptor-focused or cross-species studies.

• TMRE Assay Kit: Interpreting Mitochondrial Energy Failure

  2026-10-04

  The TMRE mitochondrial membrane potential assay kit can do more than indicate mitochondrial depolarization. This evidence-led guide explains how to interpret TMRE fluorescence within sodium-driven energy failure, distinguish apoptosis from necrosis-related mechanisms, and design stronger multidimensional mitochondrial studies.

8562 records 1/571 page Next 12345 下5页 Last page